| ||||||||||||||
|
|
|||||||||||||


Departments of *Anesthesiology and Pain Management and
Psychiatry, University of Texas Southwestern Medical Center at Dallas
Address correspondence and reprint requests to Paul F. White, PhD, MD, FANZCA, Department of Anesthesiology and Pain Management, University of Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., F2.208, Dallas, TX 75390-9068. Address e-mail to paul.white{at}utsouthwestern.edu
| Abstract |
|---|
|
|
|---|
IMPLICATIONS: The bispectral index (BIS) value immediately before the electroconvulsive therapy (ECT) stimulus correlates with the duration of the motor and electroencephalogram (EEG) seizure activity during methohexital anesthesia. In addition, the increase in the BIS value during the ECT-induced seizure was proportional to the duration of EEG seizure activity. However, the BIS value on awakening from anesthesia varied widely, from 29 to 97.
| Introduction |
|---|
|
|
|---|
ECT is widely used to treat severe depression in patients who have not responded to standard pharmacotherapeutic drugs (7). Methohexital is the most commonly used IV anesthetic for ECT because it is less likely to interfere with ECT-induced seizure activity than propofol and thiopental (8). However, the relationship between the EEG-BIS values and clinical end-points in depressed patients undergoing ECT with methohexital anesthesia has not been studied.
We designed this study to test the hypothesis that BIS values immediately before ECT would be useful in predicting the duration of seizure activity and awakening after ECT with methohexital anesthesia. A secondary objective of this study was to assess the correlation between the changes in the BIS value during and after ECT and the durations of both motor and EEG seizure activity. Finally, we analyzed the relationship between the severity of the pre-ECT depressive symptoms and the baseline BIS value.
| Methods |
|---|
|
|
|---|
, and the EEG signal was recorded and analyzed with an A2000 BIS XP monitor. A lag time of 20 s was factored into the BIS values recorded at specific end-points because of the time required by the monitor to smooth the EEG signal; the BIS algorithm uses a rolling-averaging window to calculate the BIS value. All patients were anesthetized with a standardized technique. After pretreatment with glycopyrrolate 0.2 mg IV, methohexital 1 mg/kg IV was administered as a bolus injection over 10 s to induce unconsciousness. On loss of responsiveness to verbal commands, a blood pressure cuff was inflated on the right lower leg to isolate the circulation to the foot before succinylcholine 0.751.25 mg/kg IV was administered. All patients received labetalol 10 mg IV 1 min after succinylcholine, and ventilation was assisted with a face mask and 100% oxygen to maintain an end-expiratory carbon dioxide level of 3032 mm Hg during the ECT procedure. Patients were allowed to resume spontaneous ventilation on termination of the EEG seizure activity.
Before patients entered the study, their ECT-induced seizure threshold was determined by administering successive stimuli of increasing intensity at 30-s intervals until a generalized motor and EEG seizure was induced (9). All study patients were administered a suprathreshold electrical stimulus within 4 min after the induction of anesthesia via bifrontotemporal electrodes with a MECTA-SR1TM ECT device (MECTA Corp., Portland, OR). The durations of seizure activity were calculated as the time intervals from the ECT stimulus until cessation of tonic-clonic motor activity in the isolated foot (motor seizure time) and until the EEG activity was suppressed (EEG seizure time). The times to eye opening and responsiveness to verbal commands were assessed at 1-min intervals after the patient resumed spontaneous ventilation.
The BIS values were recorded at 20 s after the following end-points: (1) preanesthetic baseline (before induction with methohexital), (2) before ECT (immediately before the ECT stimulus was administered), (3) post-ECT maximum (after the end of the motor seizure), (4) post-ECT minimum (after the end of the EEG seizure), and (5) awakening (eye opening in response to a verbal command).
Descriptive statistics were used to characterize demographic variables for the study patients, as well as the durations of motor and EEG seizure activity. Further statistical analysis was performed by using Spearmans rank correlation test to determine the correlation between the seizure duration and BIS values at each of the end-points studied. Spearmans correlation tests were also used to examine the relationship between the BIS values and awakening after the procedure. Data are presented as a mean ± SD, median (ranges), and correlation coefficients (r), with two-tailed P values <0.05 considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
| Discussion |
|---|
|
|
|---|
A recent preliminary report suggested that patients with preexisting neurologic disorders have abnormal baseline BIS values (11). In contrast to patients with dementia, our study found no evidence that the patients level of depression before the ECT treatment affected their baseline BIS values. In fact, baseline BIS values exceeded 94 in 90% of the study cases despite the presence of moderate-to-severe depressive symptoms in the study patients. Furthermore, there was no correlation between the severity of the patients preexisting depressive symptoms (e.g., Hamilton depression score) and their baseline BIS values. These preliminary data suggest that cortical function may be less impaired in patients with depressive disorders than in those with cognitive disorders and dementias. Of importance, many of these patients were also receiving concurrent antidepressant medications.
The pattern of changes in BIS values during ECT procedures with methohexital does not follow the typical time course observed during IV anesthesia. The BIS values decreased from 97 ± 4 (baseline) to 39 ± 9 after the induction of anesthesia and then increased to a maximum value of 63 ± 15 at 6080 s after the electrical stimulus. Because seizures can also occur in anesthetized (and comatose) patients, an increase in the BIS value during anesthesia (or sedation in the intensive care unit) may indicate an inadequate sedative-hypnotic state or the occurrence of seizure activity. After the EEG seizure ended (post-ECT suppression), the BIS value was reduced to 28 ± 11 (range, 2656) as a result of post-ictal EEG depression.
In a case report, Tanabe et al. (12) reported a similar BIS pattern in a 28-yr-old patient with schizophrenia who was anesthetized with propofol. In a recent study by Gunawardane et al. (13), these investigators reported that post-ictal slow-wave EEG activity results in small BIS values that do not correlate with the patients level of consciousness after propofol anesthesia. In this study, the BIS values followed a highly variable recovery pattern from the post-ictal minimum value. Awakening occurred at BIS values ranging from 29 to 94, suggesting a variable contribution from both post-ictal EEG depression and residual methohexital-induced central nervous system depression.
The contribution of post-ictal EEG suppression suggests that even in ECT patients without preexisting EEG abnormalities, the BIS values during the emergence period may be difficult to interpret irrespective of whether methohexital or propofol is used for anesthesia. Although increased slower
and
wave activity can occur with increasing age (14), we did not find a significant correlation between the baseline BIS values and the patients ages (r = -0.2). However, an age-related increase in the duration of the EEG seizure activity was observed in this study. Of potential clinical importance, the postinduction BIS value (immediately before the electrical stimulus was applied) may prove to be useful in predicting the length of the ECT-induced seizure activity.
In conclusion, the pre-ECT stimulation BIS values correlated with the durations of both the motor and EEG seizure activity under methohexital anesthesia. However, the BIS values on awakening after ECT did not appear to correlate with the residual depressive effects of the anesthetic drug because of post-ictal EEG depression.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Dettling, I. Anghelescu, M. Bajbouj, C. A. Guevara-Cuellar, C. A. Pineda-Canar, A. Torri, S. Seiner, and S. H. Lisanby Electroconvulsive Therapy for Depression N. Engl. J. Med., February 7, 2008; 358(6): 645 - 646. [Full Text] [PDF] |
||||
![]() |
P. F. White, Q. Amos, Y. Zhang, L. Stool, M. M. Husain, L. Thornton, M. Downing, S. McClintock, and S. H. Lisanby Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anesth. Analg., July 1, 2006; 103(1): 76 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, P. F. White, L. Thornton, L. Perdue, and M. Downing The Use of Nicardipine for Electroconvulsive Therapy: A Dose-Ranging Study Anesth. Analg., February 1, 2005; 100(2): 378 - 381. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|